Category

Daily Briefs

Daily Brief TMT/Internet: Kokusai Electric , Tekscend Photomask, Taiwan Semiconductor (TSMC) – ADR, Fair Isaac Corp, Dassault Systemes , Nebius Group, Meta, JST Group, Onward Technologies and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • [Japan ECM] Kokusai Elec (6525) – Applied Materials $330mm Selldown
  • Kokusai Electric Placement – Unexpected Seller but Relatively Small Deal
  • Tekscend Photomask IPO: Forecast and Valuation
  • Taiwan Tech Weekly: Why Many Tech Companies Could Soon See Their Chip Costs Rise Substantially
  • Fair Isaac (FICO) Sidelines Equifax And Transunion With Game-Changing Pricing Model!
  • Dassault Systèmes: Inside Its 3DEXPERIENCE Overhaul- What’s Driving the Platform’s Comeback!
  • Primer: Nebius Group (NBIS US) – Oct 2025
  • Meta Blindsided: OpenAI’s Sora Dethrones Instagram Overnight!
  • JST Group IPO: The Investment Case
  • Primer: Onward Technologies (ONT IN) – Oct 2025


[Japan ECM] Kokusai Elec (6525) – Applied Materials $330mm Selldown

By Travis Lundy


Kokusai Electric Placement – Unexpected Seller but Relatively Small Deal

By Sumeet Singh

  • Applied Materials (AMAT US) is looking to raise approximately US$330m through an accelerated secondary offering for around 4.5% of Kokusai Electric (6525 JP) (KE) stock.
  • KE had seen two selldown earlier, from KKR, with mixed results. KKR just came out of its last lockup.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

Tekscend Photomask IPO: Forecast and Valuation

By Shifara Samsudeen, FCMA, CGMA

  • Tekscend Photomask (429A JP) has set the IPO pricing at JPY2,900–3,000 per share, and will offer 39.6m shares raising around ¥115-118bn (US$800m) at a valuation of ¥240-250bn.
  • The company is a leading global photomask manufacturer with strength in advanced EUV masks, and generates most of its revenue from overseas markets.
  • We have compared the company against its closest pure-play peer Photronics Inc (PLAB US)  and believe the IPO is valued attractively given its expansion plans and technological edge.

Taiwan Tech Weekly: Why Many Tech Companies Could Soon See Their Chip Costs Rise Substantially

By Vincent Fernando, CFA

  • As Chips Move to 3nm and 2nm Designs, Tech Companies Could See a Sharp Increase in Their Chip Manufacturing Cost
  • Intel (INTC.US): AMD to Submit Foundry Orders to Intel? We Think It’s Highly Unlikely. 
  • HBM Stocks Will Keep Running (Micron, SK Hynix), It’s Just the Beginning 

Fair Isaac (FICO) Sidelines Equifax And Transunion With Game-Changing Pricing Model!

By Baptista Research

  • Shares of Fair Isaac Corporation surged in recent sessions as investors digested a transformative pivot in the company’s pricing strategy and market positioning.
  • The catalyst?
  • FICO is testing a new pricing model that directly undermines the influence of the three major credit bureaus — Experian, Equifax, and TransUnion — by sidelining them in score delivery and distribution.

Dassault Systèmes: Inside Its 3DEXPERIENCE Overhaul- What’s Driving the Platform’s Comeback!

By Baptista Research

  • Dassault Systèmes had solid second-quarter and first-half results for 2025, witnessing a consistent performance across its business segments.
  • Total and software revenue grew by 6%, fueled by a 10% increase in subscription revenue and 20% growth in its 3DEXPERIENCE platform.
  • Despite the growth, the company’s EPS increased only by 4%, reaching EUR 0.30, partially due to foreign exchange headwinds affecting profitability.

Primer: Nebius Group (NBIS US) – Oct 2025

By αSK

  • Nebius Group is rapidly emerging as a key player in the high-growth AI infrastructure market, specializing in GPU-as-a-Service. The company is strategically positioned to capitalize on the surging demand for AI compute capacity.
  • A landmark multi-year, multi-billion dollar contract with Microsoft validates Nebius’ capabilities and significantly de-risks its near-term revenue trajectory. Management is guiding for a revenue run-rate of $750 million to $1 billion by the end of 2025.
  • Significant execution risks remain, including managing immense capital expenditures, navigating power and supply chain constraints, and fending off intense competition from established hyperscalers and other specialized cloud providers. Financial performance is volatile, with a history of negative margins and cash flow.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Meta Blindsided: OpenAI’s Sora Dethrones Instagram Overnight!

By Baptista Research

  • Meta Platforms is staring down a new wave of disruption just as it ramps up its ambitions in AI and immersive content.
  • On October 3rd, OpenAI’s newly launched AI-video app, Sora, surged to the No. 1 spot on Apple’s App Store, less than a week after release.
  • While Meta was showcasing the scalability of its AI infrastructure, with over 3.4 billion daily app users and expanding monetization tools, Sora quietly detonated a cultural moment.

JST Group IPO: The Investment Case

By Arun George

  • JST Group (1703609D CH) is China’s largest e-commerce SaaS ERP provider. It is seeking to raise US$250 million to US$300 million.     
  • JST (Jushuitan) is China’s largest e-commerce SaaS ERP provider in terms of relevant revenue in 2024, with a market share of 24.4%, according to CIC.
  • The investment case is bullish due to robust book-to-bill ratios, strong growth, high contract liabilities, underlying profitability and cash generation.  

Primer: Onward Technologies (ONT IN) – Oct 2025

By αSK

  • Onward Technologies is strategically pivoting from traditional IT services to high-growth, higher-margin Digital and Engineering Research & Development (ER&D) services, targeting key industrial verticals.
  • The company is well-positioned to capitalize on the significant growth projected for the Indian ER&D services market, which is driven by global trends in digital transformation, automation, and connected technologies.
  • While demonstrating strong long-term growth in revenue and profitability, the company has experienced recent margin pressure and a decline in net income, highlighting execution risks and competitive intensity.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Sihuan Pharmaceutical Hldgs, WuXi XDC Cayman , Modern Dental Group, Aimed Bio, Ottobock Human Mobility, Eurofins Scientific SE, Xuanzhu Biopharmaceutical and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Sihuan Pharma (460 HK): On Xuanzhu Biopharm’s Imminent Spin-Off
  • WuXi XDC Placement: Past Secondary Deals Weak but Stock on a Tear
  • Modern Dental Group Limited (3600) – Wednesday, Jul 9, 2025
  • Aimedbio IPO Valuation Analysis
  • Ottobock IPO: Modest Discount to Embla Despite Premium Margins and Market Share”
  • Eurofins Scientific’s Value Play: Buybacks, Biopharma, and a Digital Transformation Blitz!
  • Xuanzhu Biopharma IPO: Lacks Product Differentiation, Investors Can Give It a Pass For Now


Sihuan Pharma (460 HK): On Xuanzhu Biopharm’s Imminent Spin-Off

By David Blennerhassett

  • On the 12th November 2024, Sihuan Pharmaceutical (460 HK) proposed spinning-off the shares of Xuanzhu Biopharm on the main board of Hong Kong.
  • Xuanzhu Biopharmaceutical‘s prospectus is now out. Shares are priced at HK$11.60/share, backing out a market cap of ~HK$6bn vs. Sihuan Pharma’s HK$17.4bn market cap. Trading commences on the 15th October.
  • Sihuan Pharma will hold 49.1% post IPO. Its share price is up 189% YTD. Looks frothy. Then again, so does Hong Kong’s IPO market.

WuXi XDC Placement: Past Secondary Deals Weak but Stock on a Tear

By Nicholas Tan

  • WuXi AppTec (2359 HK) is looking to raise US$308m via selling some of its stake in WuXi XDC Cayman (2268 HK).
  • The deal is a small one, representing 4.5 days of the stock’s three month ADV, and 2.3% of total shares outstanding.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

Modern Dental Group Limited (3600) – Wednesday, Jul 9, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • Modern Dental (3600) manufactures and distributes dental prosthetics with a potential for over 15% CAGR from a share price of HKD 4.35.
  • The company generates approximately 75% of its revenue from developed markets despite its primary manufacturing facility being in Shenzhen, China.
  • Modern Dental is well-positioned to benefit from the growing global reputation of Chinese manufacturers for quality and competitive pricing.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Aimedbio IPO Valuation Analysis

By Douglas Kim

  • Our base case valuation of Aimedbio is implied market cap of 882 billion won or target price of 13,256 won per share over a one year view in 2026. 
  • This represents 21% upside over a one year period. Our cumulative sales and operating profit estimates from 2025 to 2029 are 11.4% and 48.3% lower than the company’s estimates, respectively.
  • Aimedbio is not an easy company to value. Core investment thesis of the company is that it has an excellent technologies for antibody-based therapeutics, primarily antibody-drug conjugates (ADCs).

Ottobock IPO: Modest Discount to Embla Despite Premium Margins and Market Share”

By Juan Pedro Rodríguez Serrate

  • Expected to price at near 12% discount to Embla despite superior fundamentals, higher margins, and strong recurring revenue quality.  
  • Balanced B2B/B2C mix drives sustainable mid-single-digit growth and ongoing margin expansion.
  • IPO proceeds to reduce leverage to 2.5x EBITDA, though low float and KGaA structure may cap valuation upside.

Eurofins Scientific’s Value Play: Buybacks, Biopharma, and a Digital Transformation Blitz!

By Baptista Research

  • Eurofins Scientific presented its half-year 2025 financial performance, providing insights into the company’s current standing and strategic advances.
  • The report indicates both progress and challenges in Eurofins’ operations and outlook.
  • Positively, the company achieved its targets for revenue growth, margin improvement, and robust earnings per share growth for the half-year.

Xuanzhu Biopharma IPO: Lacks Product Differentiation, Investors Can Give It a Pass For Now

By Tina Banerjee

  • Xuanzhu Biopharmaceutical has filed for IPO to raise up to HK$781M. The company plans to sell 67.3M shares at HK$11.6 per share.
  • Xuanzhu Biopharmaceutical is an innovation-driven biopharmaceutical company focused on developing treatment options in the fields of digestive diseases, oncology and non-alcoholic steatohepatitis (NASH).
  • 2026 will be an inflection point for the company with all three core products fully commercialized, but will not be enough for the company to establish a sustainable market play.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Yue Yuen Industrial Holdings, Bikaji Foods, Dabur India Ltd, Guangdong Chj Industry Co A, Oriental Food Indust Hldgs, On Holding AG, Once Upon a Farm, PBC, LG Electronics India, Select Comfort, Hyundai Motor and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Primer: Yue Yuen Industrial Holdings (551 HK) – Oct 2025
  • From Tax Tailwind to Volume Surge: Bikaji’s Next Growth Phase
  • Dabur India Ltd (DABUR IN) | Excuses Mount, Reduced Disclosures, Guidance Cut
  • Guangdong CHJ Industry Files Preliminary IPO Prospectus in Hong Kong
  • Oriental Food Industries Berhad (OFIH MK):Cheap Consumer Company with 4% Dividend Yield
  • Primer: On Holding AG (ONON US) – Oct 2025
  • Once Upon a Farm (OFRM): Peeking at the IPO Prospectus of a Fresh Food Consumer Company
  • LG Electronics India IPO: The Good,The Bad and Valuations. Expect Listing Pop
  • Primer: Select Comfort (SNBR US) – Oct 2025
  • Sanae Takaichi To Become Prime Minister of Japan – Negative Impact on Korean Auto Makers


Primer: Yue Yuen Industrial Holdings (551 HK) – Oct 2025

By αSK

  • World’s Largest Footwear Manufacturer: Yue Yuen is the global leader in athletic and casual footwear manufacturing, producing for top-tier brands like Nike, Adidas, and New Balance. Its immense scale provides significant competitive advantages.
  • Dual Business Model with Integrated Retail: The company operates a core manufacturing (OEM/ODM) business and a significant sportswear retail and distribution arm in Greater China, Pou Sheng International (3813 HK). This provides diversification and end-to-end solutions for its brand partners.
  • Challenging Near-Term Outlook but Attractive Valuation: While facing headwinds from rising labor costs, geopolitical uncertainties, and soft consumer demand in its retail segment, the company’s valuation appears compelling. Strong recent growth in net income and a high dividend yield present a potentially attractive risk/reward profile for long-term investors.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


From Tax Tailwind to Volume Surge: Bikaji’s Next Growth Phase

By Sudarshan Bhandari

  • 94% of Bikaji’s revenue now falls under favorable GST slab due to the recent rate cut, positioning it to gain significant market share through lower consumer prices.
  • The company is strategically passing on the tax benefit to consumers via higher grammage and lower MRP, which is expected to drive an incremental 2-3% volume growth while sustaining margins
  • The company has the immediate manufacturing headroom and distribution reach to capture the expected volume surge without major, immediate capital expenditure.

Dabur India Ltd (DABUR IN) | Excuses Mount, Reduced Disclosures, Guidance Cut

By Pranav Bhavsar

  • Dabur India Ltd (DABUR IN) ‘s business is contracting in volume and value, with declining margins, masking structural weakness through recurring excuses and shifting narratives across seasons and quarters.
  • Disclosure standards have been reduced; management hides key metrics citing “competitive sensitivity,” obscuring true demand, volume trends, and domestic business performance.
  • Q2 guidance cut to mid-single-digit growth confirms prior double-digit guidance was untenable, exposing weak underlying demand and the market’s slow recognition of systemic underperformance.

Guangdong CHJ Industry Files Preliminary IPO Prospectus in Hong Kong

By Douglas Kim

  • Guangdong Chj Industry Co A (002345 CH) (CHJ) submitted an application to list H-shares on the Main Board of the Hong Kong Stock Exchange.
  • Despite higher valuation multiples, the company has been able to successfully generate higher sales and profits in the past several years. 
  • The high and rising global gold prices have created a strong loyal customers and investor base that could positively impact this IPO on the HK Stock Exchange. 

Oriental Food Industries Berhad (OFIH MK):Cheap Consumer Company with 4% Dividend Yield

By Punit Khanna

  • Makes branded and contract manufacturing snack food and confectionaries in Melaka Malaysia
  • Super Ring is its own brand which is very popular among customers for its unique flavour
  • Company is expanding capacity indicating the future revenue and profit grow

Raising Money for Persons with Disabilities in Singapore

For your kind consideration

This report has been prepared by Vriddhi Consulting, founded by Punit and Debjani Khanna. A portion of the research was contributed by Shubham Khanna, an individual on the autism spectrum. We are grateful to Smartkarma for providing a platform to share this research and amplify its impact.

All proceeds from the publication of this report will be donated to support people with disabilities in Singapore. If you find this report valuable, we invite you to support our campaign, “Raising Money for Persons with Disabilities in Singapore.” Every contribution directly benefits the Goh Chok Tong Enable Fund and qualifies for a 250% tax deduction for Singapore tax residents.

To contribute, please visit this URL.


Primer: On Holding AG (ONON US) – Oct 2025

By αSK

  • On Holding AG is a high-growth premium sportswear brand that has rapidly gained market share through innovative products, particularly its patented CloudTec® cushioning technology, and effective marketing strategies.
  • The company demonstrates a strong financial profile with impressive revenue growth, high gross margins, and a robust balance sheet with more cash than debt, enabling significant reinvestment into global expansion and product diversification.
  • Key risks to the investment thesis include a high valuation that prices in significant future growth, intense competition from established industry giants, and potential margin pressures from currency fluctuations and tariffs.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Once Upon a Farm (OFRM): Peeking at the IPO Prospectus of a Fresh Food Consumer Company

By IPO Boutique

  • They are driving systemic change in childhood nutrition with real, organic, farm-fresh food–made with no added sugar, no preservatives, and nothing artificial.
  • Their net sales were $94.3 million and $156.8 million and their net loss was $17.6 million and $23.8 million in 2023 and 2024, respectively.
  • The current government shutdown could delay the debut of this IPO due to the SEC unable to deem IPOs “effective” in a timely manner. 

LG Electronics India IPO: The Good,The Bad and Valuations. Expect Listing Pop

By Devi Subhakesan

  • LG Electronics India (LGEIL) ’s USD 1.3 bn IPO, which opened on October 6, closes for subscription today, October 9, and is expected to list on October 14th.
  • LGEIL has secured Rs34.7 bn from anchor investors ahead of its Rs116.1 bn IPO, signaling a likely strong oversubscription at close today.
  • LGEIL IPO, priced at a steep discount to peers do not fully reflect company’s comparative strengths – strong market leadership, high returns and growth potential. Expect listing pop of 30%+.

Primer: Select Comfort (SNBR US) – Oct 2025

By αSK

  • Select Comfort, operating as Sleep Number, is facing significant financial headwinds, evidenced by a consistent decline in revenue and a shift from profitability to net losses over the past three years. This is reflected in the negative compound annual growth rates across all key financial metrics over the last decade.
  • The company’s core competitive advantage lies in its patented, adjustable air-chambered smart bed technology (Sleep Number 360) and a direct-to-consumer (DTC) sales model. This allows for brand control and higher potential margins, but also necessitates significant marketing expenditure.
  • The mattress industry is intensely competitive and sensitive to macroeconomic conditions affecting consumer discretionary spending. While the trend towards health and wellness and smart home technology presents an opportunity, the company faces threats from both traditional players and nimble online ‘bed-in-a-box’ competitors.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Sanae Takaichi To Become Prime Minister of Japan – Negative Impact on Korean Auto Makers

By Douglas Kim

  • Sanae Taikichi will become the next Prime Minister of Japan. This is likely to have a Negative impact on the Korean automakers including Hyundai Motor and Kia Corp.
  • Sanae Takaichi is a firm advocate of the late Prime Minister Shinzo Abe’s “Abenomics” strategy to boost the economy with aggressive spending and easing monetary policy.
  • The weakening JPY combined with existing tariff rate advantage versus the South Korea could further positively impact the Japanese auto makers versus the Korean auto makers. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Sony Financial Group, Japan Post Bank, Vingroup Jsc, Canara Robeco AMC, Fermi, Korea Stock Exchange KOSPI 200, Impax Asset Management, Wealthfront Corporation, Ethos Technologies, Kobo Resources and more

By | Daily Briefs, Financials

In today’s briefing:

  • [Japan Event] Sony Financial (8729 JP) Moves On From ToSTNeT-3 Buybacks, Now In the Market
  • The Oct 2025 TOPIX FFW Rebal – $35bn of Flows To Trade
  • Vietnam: Global Index Inclusion & Passive Flows
  • Canara Robeco AMC IPO: Fairly Valued Given Strong Growth but Small Size
  • Fermi (FRMI): The Devil Is In The Footnotes, Hidden Risk Triggers
  • KOSPI 200 Tactical Outlook As Treasury Share Cancellations Impact Passive Flows
  • Impax Asset Management Group plc – AUM flat in Q4, ‘solid evidence flows are stabilising’
  • Wealthfront Corporation (WLTH): Peeking at the IPO Prospectus of as Financial Solutions Platform
  • Ethos Technologies (LIFE): Peeking at the IPO Prospectus of Insurance Platform Company
  • KRI: High Grade Hit at the Road Cut Zone & More Drill Results


[Japan Event] Sony Financial (8729 JP) Moves On From ToSTNeT-3 Buybacks, Now In the Market

By Travis Lundy

  • Sony Financial Group (8729 JP) started ToSTNeT-3 buybacks last week and did one this week to jumpstart the buyback, cushioning the Nikkei 225 deletion on 29 Sep and subsequent overhang.
  • In three ToSTNeT-3 buybacks in 6 trading days spending ¥28.9bn, the company bought back 177.513mm shares or 2.5% of shares out, or about 6.2% of Max Real World Float (MRWF).
  • With ¥71.1bn left, at last that’s 460mm shares, or 16.2% of MRWF. Over 10mos that is 1.62%/month. That will boost Mar26 DPS, Mar27 DPS projections, EPS, etc.

The Oct 2025 TOPIX FFW Rebal – $35bn of Flows To Trade

By Travis Lundy

  • Once every quarter the TSE reassesses free float weights for a set of companies whose fiscal years ended 7-10 months prior. Calendar Q1 is the biggie so October is too.
  • This year, as companies have made dramatic changes in their shareholder registries through crossholder sales, activist acquisitions, and other, there are some big changes and big dollar changes.
  • We see nearly 600 FFW changes up and down, and then nearly 1,100 stocks which see a significant (average 0.5x ADV) funding trade. $35bn in total.

Vietnam: Global Index Inclusion & Passive Flows

By Brian Freitas

  • After years of being on the watchlist, Vietnam will be added to a global index in September 2026 as long as progress is made on one key issue.
  • The final decision will be made in March 2026, and the implementation of the inclusion will take place in phases.
  • We currently see 21 stocks meeting the inclusion criteria. There are others that are close to the inclusion thresholds, and the list will change over the next few months.

Canara Robeco AMC IPO: Fairly Valued Given Strong Growth but Small Size

By Hong Jie Seow

  • Canara Robeco AMC (570515Z IN) is looking to raise up to US$150m in its upcoming India IPO.
  • Overall, revenue increased annually at about 39% since FY22 and based on 9M25 numbers, Canara’s FY25 performance is on track to surpass FY24’s levels
  • We have looked at the company’s past performance in our previous note. In this note, we talk about valuations.

Fermi (FRMI): The Devil Is In The Footnotes, Hidden Risk Triggers

By Evan Campbell, CFA

  • Private debt terms signal stress. The primary lender’s 1YR term facility implies a 50%+ IRR via a MOIC option. This is under-covered and signals constrained alternatives.
  • Calendar precedes cash. Fixed obligations hit before revenue, so equity value is driven by sequencing rather than AI demand narratives.
  • Underwriting focus. Binding large-scale lease, funded bridge through fuel and logistics, and a credible take-out or refinance of the short-tenor facility.

KOSPI 200 Tactical Outlook As Treasury Share Cancellations Impact Passive Flows

By Nico Rosti

  • Sanghyun Park recently posted a comprehensive insight regarding South Korea’s move toward forcing firms to cancel treasury shares. I invite you to read it if you haven’t yet.
  • The KOSPI 200 index passive flows will probably be deeply impacted by this legal reform, we could see this happening soon, before the December KOSPI 200 reshuffle.
  • Since funds moves could start any time, here is a quantitative-model-based analysis of the most probable trends, with a short-term focus (next 3-4 weeks).

Impax Asset Management Group plc – AUM flat in Q4, ‘solid evidence flows are stabilising’

By Equity Development

  • AUM closed FY25 (1 Oct 24 – 30 Sep 25) on £26.1bn, above our previous forecast of £25.0bn.
  • In Q4 (Jul – Sep), investment performance contributed +£1.4bn (+5.3%), offset by net outflows of -£1.4bn, in a quarter of heavy outflows for equity funds more generally (page 3).
  • Impax’s outflows were slightly up on the previous quarter (-£1.3bn), but were a marked improvement over H1, which saw £10.2bn of net outflows, dominated by the loss of £6.2bn of St James’s Place mandates.

Wealthfront Corporation (WLTH): Peeking at the IPO Prospectus of as Financial Solutions Platform

By IPO Boutique

  • Their platform assets increased from $57.6 billion as of January 31, 2024 to $80.2 billion as of January 31, 2025, representing 39% year-over-year growth.
  • Tiger Global is the company’s largest shareholder, holding a 19.7% stake, followed by major backers such as Benchmark Capital, Index Ventures, Ribbit Capital, and Greylock Partners.
  • The current government shutdown could delay the debut of this IPO due to the SEC unable to deem IPOs “effective” in a timely manner. 

Ethos Technologies (LIFE): Peeking at the IPO Prospectus of Insurance Platform Company

By IPO Boutique

  • Their total revenue was $159.8 million and $254.9 million and their net income was $1.69 million and $48.83 million in 2023 and 2024, respectively.
  • Google Ventures, Sequoia and Accel are shareholders in this high profile company. 
  • The current government shutdown could delay the debut of this IPO due to the SEC unable to deem IPOs “effective” in a timely manner.

KRI: High Grade Hit at the Road Cut Zone & More Drill Results

By Atrium Research

  • Kobo announced results from its ongoing 2025 diamond drill program with an impressive, and shallow, highlight intercept of 3.87 g/t Au over 17m.
  • Today’s results represent the first six holes from KRI’s ongoing 12,000-15,000m diamond drill program (launched on September 4th, 2025).
  • Over the last 2 months, KRI has had several other updates, including the closing of a financing for $4M (not including in our assumed cash balance), the recommencement of its 2025 drill program, and the announcement of a new earn-in agreement on the Yakassé Gold Project.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Quanta Computer, Taekwang Industrial, Kokusai Electric , Japan Post Bank, Sony Financial Group, Johns Lyng, Vingroup Jsc, Advantest Corp and more

By | Daily Briefs, Most Read

In today’s briefing:

  • WisdomTree Emerging Markets High Dividend Index Rebalance: US$2.3bn Round-Trip Trade
  • Korea’s Mandatory Treasury Share Cancellation Situation Creates New Passive Flow Dynamics
  • [Japan ECM] Kokusai Elec (6525) – Applied Materials $330mm Selldown
  • The Oct 2025 TOPIX FFW Rebal – $35bn of Flows To Trade
  • [Japan Event] Sony Financial (8729 JP) Moves On From ToSTNeT-3 Buybacks, Now In the Market
  • Johns Lyng (JLG AU): 8th October Vote On PEP’s Offer
  • Vietnam: Global Index Inclusion & Passive Flows
  • [Quiddity Index] HUGE Rally Brings Advantest to Nikkei Capping Territory
  • Kokusai Electric Placement – Unexpected Seller but Relatively Small Deal
  • US Shutdown: A Means To An End


WisdomTree Emerging Markets High Dividend Index Rebalance: US$2.3bn Round-Trip Trade

By Brian Freitas

  • The WisdomTree Emerging Markets High Dividend Index is a fundamentally weighted index that measures the performance of high dividend yield stocks within emerging markets.
  • The changes at the October rebalance were announced after market close on 6 October with implementation scheduled at the close on 15 October.
  • There are 217 adds and 224 deletes for the index with an estimated round-trip trade of US$2.3bn. There are many stocks with over 2x ADV to trade.

Korea’s Mandatory Treasury Share Cancellation Situation Creates New Passive Flow Dynamics

By Sanghyun Park

  • KRX may preemptively adjust KOSPI 200 screening, switching from full market cap to market cap excluding treasury shares for index inclusion.
  • With treasury-share cancellation likely this quarter, KRX may act before June ’26. For December KOSPI 200, we should run both full-cap and ex-treasury screens; flows could behave unusually.
  • Focusing on Hanssem (009240 KS) and Taekwang (003240 KS); borderline, high treasury shares, potential KOSPI 200 exclusion, making them key flow-sensitive setups for December reshuffle.

[Japan ECM] Kokusai Elec (6525) – Applied Materials $330mm Selldown

By Travis Lundy


The Oct 2025 TOPIX FFW Rebal – $35bn of Flows To Trade

By Travis Lundy

  • Once every quarter the TSE reassesses free float weights for a set of companies whose fiscal years ended 7-10 months prior. Calendar Q1 is the biggie so October is too.
  • This year, as companies have made dramatic changes in their shareholder registries through crossholder sales, activist acquisitions, and other, there are some big changes and big dollar changes.
  • We see nearly 600 FFW changes up and down, and then nearly 1,100 stocks which see a significant (average 0.5x ADV) funding trade. $35bn in total.

[Japan Event] Sony Financial (8729 JP) Moves On From ToSTNeT-3 Buybacks, Now In the Market

By Travis Lundy

  • Sony Financial Group (8729 JP) started ToSTNeT-3 buybacks last week and did one this week to jumpstart the buyback, cushioning the Nikkei 225 deletion on 29 Sep and subsequent overhang.
  • In three ToSTNeT-3 buybacks in 6 trading days spending ¥28.9bn, the company bought back 177.513mm shares or 2.5% of shares out, or about 6.2% of Max Real World Float (MRWF).
  • With ¥71.1bn left, at last that’s 460mm shares, or 16.2% of MRWF. Over 10mos that is 1.62%/month. That will boost Mar26 DPS, Mar27 DPS projections, EPS, etc.

Johns Lyng (JLG AU): 8th October Vote On PEP’s Offer

By David Blennerhassett

  • On the 11th July, PEP offered A$4/share for integrated building services provider Johns Lyng (JLG AU), a 77% premium to undisturbed. CEO Scott Didier, JLG’s largest shareholder (17.62%), was supportive.
  • Pricing is okay. The absence of a final year fully franked dividend, which was teased at the onset, was ostensibly disappointing.
  • The Scheme Booklet is now out, with a Scheme Meeting on the 8th October, and expected implementation on or before the 23rd October. The IE (Kroll) says “fair & reasonable“.

Vietnam: Global Index Inclusion & Passive Flows

By Brian Freitas

  • After years of being on the watchlist, Vietnam will be added to a global index in September 2026 as long as progress is made on one key issue.
  • The final decision will be made in March 2026, and the implementation of the inclusion will take place in phases.
  • We currently see 21 stocks meeting the inclusion criteria. There are others that are close to the inclusion thresholds, and the list will change over the next few months.

[Quiddity Index] HUGE Rally Brings Advantest to Nikkei Capping Territory

By Travis Lundy

  • Monday’s huge post-election move in Nikkei 225 and Advantest Corp (6857 JP) caused Advantest to clear 10.00% realtime at day-end. Assuming nothing changes til end-Jan-2026, Advantest gets capped at end-Mar-2026
  • As of today, that would be roughly 1.6x ADV and US$2.75bn but it would be 10% of Max Real World Float. 
  • This is far off but should stay on the radar. Softbank Group (9984 JP) is close behind at 8.7%. 15+% outperformance would put it in capping territory too.  

Kokusai Electric Placement – Unexpected Seller but Relatively Small Deal

By Sumeet Singh

  • Applied Materials (AMAT US) is looking to raise approximately US$330m through an accelerated secondary offering for around 4.5% of Kokusai Electric (6525 JP) (KE) stock.
  • KE had seen two selldown earlier, from KKR, with mixed results. KKR just came out of its last lockup.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

US Shutdown: A Means To An End

By Alastair Newton

  • The Democrats opted for a US government shutdown despite the Administration being well prepared for what it sees as an opportunity to promote its longer-term agenda.
  • While they hold out, the president’s ‘grim reaper’, OMB Director Russell Vought, will have a free hand to cut the size of government and pursue his unitary executive vision.
  • Some of his actions will undoubtedly be challenged in the courts, but the signs are that the Supreme Court will continue to side firmly with the Administration.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief South Korea: Taekwang Industrial, Aimed Bio and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Korea’s Mandatory Treasury Share Cancellation Situation Creates New Passive Flow Dynamics
  • Aimedbio IPO Preview


Korea’s Mandatory Treasury Share Cancellation Situation Creates New Passive Flow Dynamics

By Sanghyun Park

  • KRX may preemptively adjust KOSPI 200 screening, switching from full market cap to market cap excluding treasury shares for index inclusion.
  • With treasury-share cancellation likely this quarter, KRX may act before June ’26. For December KOSPI 200, we should run both full-cap and ex-treasury screens; flows could behave unusually.
  • Focusing on Hanssem (009240 KS) and Taekwang (003240 KS); borderline, high treasury shares, potential KOSPI 200 exclusion, making them key flow-sensitive setups for December reshuffle.

Aimedbio IPO Preview

By Douglas Kim

  • Aimedbio is getting ready to complete its IPO in KOSDAQ in November 2025. The IPO price range is from 9,000 won to 11,000 won per share.
  • According to the bankers’ IPO price range, the expected market cap after the IPO is from 599 billion won to 732 billion won.
  • Aimedbio has advanced multiple antibody-drug conjugates (ADC) candidates into preclinical and early clinical stages.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Infomedia Ltd, Corporate Travel Management, Intermin Resources, Percheron Therapeutics , Recce Ltd and more

By | Australia, Daily Briefs

In today’s briefing:

  • Infomedia (IFM AU): Scheme Vote on 18 November
  • Infomedia (IFM AU): 18th November Vote On TPG’s Offer
  • Primer: Corporate Travel Management (CTD AU) – Oct 2025
  • Horizon Minerals Ltd – Burbanks drilling update
  • Percheron Therapeutics — Positive Phase I readout strengthens outlook
  • Recce Pharmaceuticals — Phase III Indonesian DFI trial underway


Infomedia (IFM AU): Scheme Vote on 18 November

By Arun George

  • The Infomedia Ltd (IFM AU) IE considers TPG’s A$1.70 offer fair and reasonable, as it falls within its A$1.57 to A$1.79 valuation range.
  • The scheme is conditional on FIRB approval, German FDI approval, and shareholder approval. Shareholders should be supportive, as the offer is reasonable and Infomedia’s history of non-binding bids.
  • The scheme vote is low-risk. At the last close and for a 3 December payment, the gross/annualised spread is 1.2%/7.4%.  

Infomedia (IFM AU): 18th November Vote On TPG’s Offer

By David Blennerhassett

  • Back on the 11th July,Infomedia Ltd (IFM AU), a automotive software firm, entered into a Scheme Implementation Deed with PE-outfit TPG.
  • TPG offered A$1.72/share, a 30% premium to last close. The Offer had the unanimous backing of Infomedia’s boards. All in, terms looked clean.
  • The Scheme Booklet is now out, with a Scheme Meeting on the 18th November, and expected implementation on the 3rd December. The IE (Grant Thornton) says “fair & reasonable“.

Primer: Corporate Travel Management (CTD AU) – Oct 2025

By αSK

  • Corporate Travel Management (CTD) is well-positioned to capitalize on the continued recovery and growth of the global corporate travel market, driven by its proprietary technology, global scale, and diversified client base.
  • The company’s asset-light business model and focus on small and medium-sized enterprises (SMEs) contribute to high margins and a sticky customer base, although recent performance has been impacted by macroeconomic uncertainty and weaker-than-expected government contract contributions.
  • Future growth is expected to be supported by strategic acquisitions, continued investment in technology and automation (including AI) to drive efficiencies, and the recovery of key markets like North America and Asia.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Horizon Minerals Ltd – Burbanks drilling update

By Research as a Service (RaaS)

  • Horizon Minerals Limited (ASX:HRZ) is an emerging junior gold producer with 1.8moz of gold resources located around the Kalgoorlie and Coolgardie regions of Western Australia.
  • HRZ released an update covering progress on drilling at the Burbanks project which is a two-stage, 30km drilling program covering both infill and extensional drilling.
  • Initial results from stage one demonstrates continuity in the existing resource model which should support conversion of the resource from inferred to indicated.

Percheron Therapeutics — Positive Phase I readout strengthens outlook

By Edison Investment Research

Percheron Therapeutics has reported final results from the Phase I dose escalation study of HMBD-002, its monoclonal antibody targeting VISTA, a novel immune checkpoint protein. The data confirmed the compound’s favourable safety and tolerability profile (maximum tolerated dose not reached with <10% of patients experiencing grade 3 or greater adverse events), with early signs of disease control in advanced solid tumours. The trial was not designed or sufficiently powered to demonstrate efficacy; however, evidence of stable disease (28% of cases) in an otherwise heavily pre-treated patient population (median four to five prior lines of treatment) supports Percheron’s move towards Phase II development in CY26. We expect the announcement on the Phase II design and target indications, due in Q4 CY25, as the next big catalyst for the company.


Recce Pharmaceuticals — Phase III Indonesian DFI trial underway

By Edison Investment Research

Recce has reached a key milestone with the start of patient dosing in its Phase III Indonesian-focused study of the topical gel formulation (R327G) of its lead anti-infective therapeutic drug candidate, RECCE® 327 (R327), for the treatment of diabetic foot infections (DFIs). DFIs are the leading cause of limb morbidity in diabetic patients and an area of unmet need, as currently available topical drugs have limited effectiveness. Positive Phase III results could lead to Recce’s earliest commercialisation opportunity, through a launch of R327G in South-East Asia in the DFI indication in H2 CY26. We now determine an rNPV valuation of A$600.2m (or A$2.24 per share), versus A$615.1m (or A$2.51 per share) previously.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: Tiong Woon Corp Holding, SGX Rubber Future TSR20 and more

By | Daily Briefs, Singapore

In today’s briefing:

  • Primer: Tiong Woon Corp Holding (TWC SP) – Oct 2025
  • U.S. Tire Industry Navigates Growth, Tariffs, And Strategic Shifts In 2025


Primer: Tiong Woon Corp Holding (TWC SP) – Oct 2025

By αSK

  • Tiong Woon is a key regional player in the heavy lift and haulage industry, poised to benefit from the upswing in the petrochemical, infrastructure, and construction sectors across Southeast Asia, India, and the Middle East.
  • The company demonstrates a strong growth trajectory with a 3-year revenue CAGR of 10.08% and a net income CAGR of 19.04%, supported by a strategic focus on higher-margin, larger-capacity cranes and expansion into high-growth markets.
  • Despite a positive outlook and solid financial performance, the company faces risks from market cyclicality, project delays, and margin pressure from rising costs. Its ongoing capital expenditure cycle supports long-term growth but currently weighs on free cash flow.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


U.S. Tire Industry Navigates Growth, Tariffs, And Strategic Shifts In 2025

By Vinod Nedumudy

  • U.S. tire shipments projected at a record 340.2 million units in 2025  
  •  Dynamics shift, with Chinese tire imports falling and SE Asian imports rising  
  • Top players pursue expansion, innovation, and portfolio revamp  

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Semi-Tech Group, Sa Sa International Hldgs, Midea Group, SGX Rubber Future TSR20, Horizon Robotics, Remegen and more

By | China, Daily Briefs

In today’s briefing:

  • Semi-Tech Group Pre-IPO Tearsheet
  • Sa Sa Intl (178 HK): Seemingly Too Conservative
  • Midea Group (300 HK/000333) – High Growth Is Expected to Continue in the Short Term
  • U.S. Tire Industry Navigates Growth, Tariffs, And Strategic Shifts In 2025
  • Primer: Horizon Robotics (9660 HK) – Oct 2025
  • Remegen (9995 HK): 2H25 Upfront Boost; Indication Expansion Positive; Overseas Trial Results Awaited


Semi-Tech Group Pre-IPO Tearsheet

By Nicholas Tan

  • Semi-Tech Group (1890554D CH) is looking to raise at least US$200m in its upcoming Hong Kong IPO. The deal will be run by Deutsche Bank, CICC and Guotai.
  • It is a leading provider of intelligent industrial software solutions in China.
  • With strong commercialization capabilities, ST is one of the few China-based advanced-industry intelligent manufacturing software companies to achieve profitability.

Sa Sa Intl (178 HK): Seemingly Too Conservative

By Osbert Tang, CFA

  • Sa Sa International Hldgs (178 HK)‘s 1.63x P/B is near-trough level, but the recovery in earnings in FY26 (+56.4%) and improving industry figures suggest earnings have bottomed. 
  • Its 2Q FY26 turnover grew 8.4%, accelerating from 4.7% in 1Q and -9.7% in FY25. The 1H turnover equals 49.3% of FY26F (vs. 47.2% historically). We see upgrade potential.
  • With net cash amounting to 19.3% of the share price, its 15.9x and 12.4x PERs for FY26F and FY27F do not look stretched.

Midea Group (300 HK/000333) – High Growth Is Expected to Continue in the Short Term

By Xinyao (Criss) Wang

  • Midea will achieve double-digit growth in 2025. As domestic home appliance market enters a stage of competition for existing customers, B-end market and overseas markets have become new growth keys.
  • The development path of three giants becomes clear – Midea pursues full industry chain synergy with diversified layout/digital capabilities.Haier builds a global brand matrix through high-end/localized operations.Gree is lagging behind.
  • For mature industry leading enterprises, 10-18x P/E is reasonable, or market value of RMB430-855bn based on Midea’s 2025 net profit forecast. Considering higher growth, valuation would be higher than Haier.

U.S. Tire Industry Navigates Growth, Tariffs, And Strategic Shifts In 2025

By Vinod Nedumudy

  • U.S. tire shipments projected at a record 340.2 million units in 2025  
  •  Dynamics shift, with Chinese tire imports falling and SE Asian imports rising  
  • Top players pursue expansion, innovation, and portfolio revamp  

Primer: Horizon Robotics (9660 HK) – Oct 2025

By αSK

  • Horizon Robotics is a leading provider of integrated hardware and software solutions for Advanced Driver-Assistance Systems (ADAS) and autonomous driving (AD) in China, positioning it to capitalize on the country’s rapidly growing smart vehicle market.
  • The company is expected to experience significant near-term tailwinds from passive capital inflows due to its inclusion and increased weighting in major stock indices, as highlighted by Smartkarma analyst Brian Freitas.
  • While demonstrating explosive revenue growth, the company remains in a high-investment phase, characterized by substantial operating losses and negative cash flow, reflecting the capital-intensive nature of the semiconductor and AI industries.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Remegen (9995 HK): 2H25 Upfront Boost; Indication Expansion Positive; Overseas Trial Results Awaited

By Tina Banerjee

  • Remegen (9995 HK) recorded revenue of RMB 1.1B, a 48% rise YoY, driven by robust sales growth of telitacicept (treatment of autoimmune diseases) and disitamab vedotin (treatment of solid tumors).
  • Remegen entered into a license agreement with Vor Biopharma (telitacicept global rights) and Santen (RC28-E rights in China and other few countries). Upfront payments to reflect in revenues in 2H25.  
  • Vor Biopharma is conducting a global multi-center Phase III clinical trial (first patient enrolled in August 2024, in U.S) of telitacicept for the treatment of patients with myasthenia gravis (gMG).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Quantitative Analysis: HK Short Interest Weekly: CSPC Pharma and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • HK Short Interest Weekly: CSPC Pharma, HSBC, Wuxi Apptec, China Mobile
  • JPX Margin Trading Weekly (Oct 3rd): IHI, Nippon Steel, Nitori, Ai Robotics
  • STAR50 Index Earning Revision (Sep): LOONGSON TECHNOLOGY, TRINA SOLAR, Xinjiang Daqo


HK Short Interest Weekly: CSPC Pharma, HSBC, Wuxi Apptec, China Mobile

By Ke Yan, CFA, FRM

  • We analyzed the latest HK SFC report for aggregate short position as of Sep 26th.
  • Top short increases and decreases were tabulated for one week and four week period.
  • We highlight short changes in CSPC Pharma, HSBC, Wuxi Apptec, China Mobile.

JPX Margin Trading Weekly (Oct 3rd): IHI, Nippon Steel, Nitori, Ai Robotics

By Ke Yan, CFA, FRM

  • We analyzed the changes in margin trading positions of JPX stocks as of Oct 3rd. The aggregated net margin trading position is USD17,873m.
  • We tabulate league tables for top/bottom net long/short of margin trading by value, net margin buy as multiple of ADT.
  • We highlight net margin buy/sell changes in IHI, Nippon Steel, Nitori, Ai Robotics, Pan Pacific International, Mitsubishi UFJ Financial, Mitsui O.S.K. Lines, Disco, Kintetsu, Yamada, Ihi.

STAR50 Index Earning Revision (Sep): LOONGSON TECHNOLOGY, TRINA SOLAR, Xinjiang Daqo

By Ke Yan, CFA, FRM

  • We analysed the earning revision of component stocks of STAR50 in the past month.
  • We tabulated stocks with the top impact on index’s EPS, stocks’ EPS revision, and revenue revision.
  • We highlighted EPS revision on LOONGSON TECHNOLOGY, TRINA SOLAR, Xinjiang Daqo, SHENGYI ELECTRONICS, QI AN XIN TECHNOLOGY, NATIONAL SILICON INDUSTRY, JINKO SOLAR, Shengyi Electronics, Qi An Xin Technology, Jinko Solar.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars